From a cellular laboratory viewpoint, Relafen 750 (Naproxen ) presents a unique case. Its mechanism of effect primarily involves inhibiting cyclooxygenase proteins, specifically COX-1 and COX-2, thereby reducing prostaglandin generation. This leads to decreased swelling and temperature . The medication's relatively long half-life and specific tissu